UK markets closed

Qiwi plc (QIWI)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
5.670.00 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 355.58M
Enterprise value -308.12M
Trailing P/E 1.19
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.50
Price/book (mrq)0.48
Enterprise value/revenue -0.00
Enterprise value/EBITDA -0.02

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 30.00%
S&P500 52-week change 320.07%
52-week high 35.67
52-week low 35.67
50-day moving average 35.67
200-day moving average 35.67

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 562.71M
Implied shares outstanding 662.71M
Float 844.82M
% held by insiders 113.96%
% held by institutions 13.66%
Shares short (28 Mar 2024) 41.19M
Short ratio (28 Mar 2024) 4N/A
Short % of float (28 Mar 2024) 42.15%
Short % of shares outstanding (28 Mar 2024) 41.89%
Shares short (prior month 29 Feb 2024) 41.13M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 44.32
Payout ratio 421.39%
Dividend date 314 Dec 2021
Ex-dividend date 403 Dec 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in RUB.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 23.13%
Operating margin (ttm)18.66%

Management effectiveness

Return on assets (ttm)9.02%
Return on equity (ttm)26.93%

Income statement

Revenue (ttm)67.93B
Revenue per share (ttm)1,083.18
Quarterly revenue growth (yoy)32.80%
Gross profit (ttm)N/A
EBITDA 16.14B
Net income avi to common (ttm)15.72B
Diluted EPS (ttm)4.94
Quarterly earnings growth (yoy)-35.80%

Balance sheet

Total cash (mrq)59.36B
Total cash per share (mrq)946.57
Total debt (mrq)4.4B
Total debt/equity (mrq)6.45%
Current ratio (mrq)1.98
Book value per share (mrq)1,070.80

Cash flow statement

Operating cash flow (ttm)8.94B
Levered free cash flow (ttm)10.49B